Richard G. Pestell
Founder at Prostagene LLC
Richard G. Pestell active positions
Companies | Position | Start | End |
---|---|---|---|
Prostagene LLC
Prostagene LLC BiotechnologyHealth Technology Prostagene LLC operates as a biotechnology company that develops treatments for cancer. It offers gene-based prostate cancer testing technology, and cancer metastasis prevention and treatment technology. The company was founded by Richard G. Pestell and is headquartered in Wynnewood, PA. | Founder | 2011-01-31 | - |
Chairman | 2011-01-31 | - | |
Chief Executive Officer | 2011-01-31 | - | |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
EcoGenome LLC
EcoGenome LLC Medical/Nursing ServicesHealth Services EcoGenome LLC is an American biotechnology company that focuses on developing diagnostic tests for prostate cancer. The company is located in the US. The company aims to provide informed cancer therapy choices by identifying individual tumor genetic vulnerabilities. Genetic changes within a tumor may alter the response to therapy, and testing an individual patient's tumor for therapeutic vulnerabilities may provide more precise therapy planning. | Chief Executive Officer | - | - |
Career history of Richard G. Pestell
Former positions of Richard G. Pestell
Companies | Position | Start | End |
---|---|---|---|
CYTODYN INC. | Director/Board Member | 2018-11-15 | 2019-07-24 |
Chief Tech/Sci/R&D Officer | 2018-07-11 | 2019-07-24 | |
Thomas Jefferson University | Corporate Officer/Principal | 2004-12-31 | 2016-11-30 |
Georgetown University | Corporate Officer/Principal | 2001-12-31 | 2014-12-31 |
Training of Richard G. Pestell
The University of Western Australia Business School | Doctorate Degree |
University of Melbourne | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
United States | 7 |
Australia | 3 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Doctorate Degree | 2 |
Sectoral
Consumer Services | 6 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CYTODYN INC. | Health Technology |
Private companies | 3 |
---|---|
Prostagene LLC
Prostagene LLC BiotechnologyHealth Technology Prostagene LLC operates as a biotechnology company that develops treatments for cancer. It offers gene-based prostate cancer testing technology, and cancer metastasis prevention and treatment technology. The company was founded by Richard G. Pestell and is headquartered in Wynnewood, PA. | Health Technology |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Commercial Services |
EcoGenome LLC
EcoGenome LLC Medical/Nursing ServicesHealth Services EcoGenome LLC is an American biotechnology company that focuses on developing diagnostic tests for prostate cancer. The company is located in the US. The company aims to provide informed cancer therapy choices by identifying individual tumor genetic vulnerabilities. Genetic changes within a tumor may alter the response to therapy, and testing an individual patient's tumor for therapeutic vulnerabilities may provide more precise therapy planning. | Health Services |
- Stock Market
- Insiders
- Richard G. Pestell
- Experience